Matthew Perez
Matt has helped recover hundreds of millions of dollars on behalf of consumers, insurers, pension funds, businesses, and governmental entities.
Matt has helped recover hundreds of millions of dollars on behalf of consumers, insurers, pension funds, businesses, and governmental entities.
Matt represents, individuals, businesses, public pension funds, and insurers in complex antitrust class actions. His practice spans a wide range of industries but with particular focus on pharmaceuticals and financial services. He currently litigates several pay-for-delay antitrust actions on behalf of consumers, health plans, and insurers alleging delayed generic entry for Opana ER, Bystolic, Sensipar, Xyrem, and Zetia. He has or is currently representing investors in financial services and commodity markets, including pension funds and traders in foreign exchange, international sovereign bonds, interest rate and credit derivatives, and commodity futures markets.
Matt previously worked for a nationally-recognized class action law firm and the New York State Office of the Attorney General Antitrust Bureau. He received the Louis J. Lefkowitz Memorial Award for his work investigating bid rigging and other illegal conduct in the municipal bond derivatives market, resulting in more than $260 million in restitution to municipalities and nonprofit entities. He also investigated pay-for-delay matters involving multinational pharmaceutical companies.
Matt has been named a “Rising Star” by The Legal 500. In law school, he received the Jacob Burns Medal for Outstanding Contribution to the Law School. He was an intern for Judge Richard B. Lowe, III, in the New York Supreme Court Commercial Division.
Matt is also a member of the New York State Bar Association Antitrust Section’s Executive Committee. He also serves as the chair of the Antitrust Section’s Class Action and Private Litigation Committee.
